MA42290A - Gel fluide ophtalmique de bimatoprost - Google Patents

Gel fluide ophtalmique de bimatoprost

Info

Publication number
MA42290A
MA42290A MA042290A MA42290A MA42290A MA 42290 A MA42290 A MA 42290A MA 042290 A MA042290 A MA 042290A MA 42290 A MA42290 A MA 42290A MA 42290 A MA42290 A MA 42290A
Authority
MA
Morocco
Prior art keywords
fluid gel
ophthalmic fluid
bimatoprost ophthalmic
bimatoprost
gel
Prior art date
Application number
MA042290A
Other languages
English (en)
Other versions
MA42290B1 (fr
Inventor
Pierre-Paul Elena
Heinz Polzer
Jürgen Senge
Original Assignee
Medproject Pharma Enwicklungs Und Vertriebsgesellschaft Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medproject Pharma Enwicklungs Und Vertriebsgesellschaft Mbh filed Critical Medproject Pharma Enwicklungs Und Vertriebsgesellschaft Mbh
Publication of MA42290A publication Critical patent/MA42290A/fr
Publication of MA42290B1 publication Critical patent/MA42290B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
MA42290A 2015-06-09 2016-06-08 Gel fluide ophtalmique de bimatoprost MA42290B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15171233.8A EP3103439B1 (fr) 2015-06-09 2015-06-09 Gel ophtalmique de bimatoprost applicable en gouttes
PCT/EP2016/062990 WO2016198434A1 (fr) 2015-06-09 2016-06-08 Gel ophthalmique à base de bimatoprost administrable sous forme de gouttes
EP16729525.2A EP3307241B8 (fr) 2015-06-09 2016-06-08 Gel fluide ophtalmique de bimatoprost

Publications (2)

Publication Number Publication Date
MA42290A true MA42290A (fr) 2016-12-15
MA42290B1 MA42290B1 (fr) 2018-11-30

Family

ID=53298285

Family Applications (1)

Application Number Title Priority Date Filing Date
MA42290A MA42290B1 (fr) 2015-06-09 2016-06-08 Gel fluide ophtalmique de bimatoprost

Country Status (27)

Country Link
US (1) US10314780B2 (fr)
EP (2) EP3103439B1 (fr)
JP (1) JP6342087B1 (fr)
KR (1) KR101889878B1 (fr)
CN (1) CN107771074B (fr)
AU (1) AU2016277336B2 (fr)
BR (1) BR112017026552B1 (fr)
CA (1) CA2985897C (fr)
CY (1) CY1120883T1 (fr)
DK (1) DK3307241T3 (fr)
ES (2) ES2747302T3 (fr)
HR (1) HRP20181840T1 (fr)
IL (1) IL256071B (fr)
LT (1) LT3307241T (fr)
MA (1) MA42290B1 (fr)
MX (1) MX2017015835A (fr)
PL (2) PL3103439T3 (fr)
PT (1) PT3307241T (fr)
RS (1) RS57948B1 (fr)
RU (1) RU2698456C2 (fr)
SA (1) SA517390480B1 (fr)
SG (1) SG11201708642VA (fr)
SI (1) SI3307241T1 (fr)
TN (1) TN2017000445A1 (fr)
TR (1) TR201815791T4 (fr)
UA (1) UA121139C2 (fr)
WO (1) WO2016198434A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112566622A (zh) * 2018-06-19 2021-03-26 细胞疗法有限责任公司 用于治疗青光眼或高眼压症的包含眼内压降低剂、cnp化合物、npr-b化合物、tie-2激动剂或神经营养剂的缓释药物递送系统
CN110200904B (zh) * 2019-05-27 2021-07-23 上海昊海生物科技股份有限公司 一种降眼压缓释滴眼组合物及其制备方法
US11786538B2 (en) 2019-12-11 2023-10-17 Somerset Therapeutics, Llc Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties
US12064440B2 (en) 2022-03-21 2024-08-20 Somerset Therapeutics, Llc Ophthalmic gel compositions of bimatoprost and timolol and associated methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4209722C3 (de) 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
DE10132876A1 (de) * 2001-07-06 2003-01-30 Medproject Pharma Entwicklungs Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
FR2918891B1 (fr) * 2007-07-20 2009-09-25 Thea Sa Lab Solution ophtalmique a base de prostaglandines sans conservateur
EP2127638A1 (fr) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Procédé et composition pour traiter l'hypertension oculaire et le glaucome
FR2961694B1 (fr) * 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
AU2011282679A1 (en) 2010-07-29 2013-03-07 Allergan, Inc. Preservative free bimatoprost solutions
EA201301332A1 (ru) * 2011-05-27 2014-06-30 Рациофарм Гмбх ОФТАЛЬМОЛОГИЧЕСКИЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ АНАЛОГ PGF2α
WO2013013143A1 (fr) * 2011-07-20 2013-01-24 Allergan, Inc. Combinaison à dose fixe de bimatoprost et brimonidine
CN104288092A (zh) * 2013-07-16 2015-01-21 广东东阳光药业有限公司 拉坦前列素滴眼剂
CN104622798B (zh) * 2014-12-05 2017-12-22 广东东阳光药业有限公司 一种含有他氟前列素的滴眼液及其制备方法

Also Published As

Publication number Publication date
PL3103439T3 (pl) 2019-12-31
EP3103439A1 (fr) 2016-12-14
SG11201708642VA (en) 2017-11-29
KR101889878B1 (ko) 2018-08-20
US10314780B2 (en) 2019-06-11
UA121139C2 (uk) 2020-04-10
JP2018518466A (ja) 2018-07-12
US20180228724A1 (en) 2018-08-16
AU2016277336A1 (en) 2017-11-23
DK3307241T3 (en) 2018-11-05
CA2985897C (fr) 2019-10-01
EP3307241A1 (fr) 2018-04-18
SI3307241T1 (sl) 2018-12-31
HRP20181840T1 (hr) 2019-01-11
WO2016198434A1 (fr) 2016-12-15
EP3103439B1 (fr) 2019-08-07
RU2698456C2 (ru) 2019-08-27
ES2703432T3 (es) 2019-03-08
RU2017138099A (ru) 2019-07-10
RU2017138099A3 (fr) 2019-07-17
ES2747302T3 (es) 2020-03-10
MX2017015835A (es) 2018-08-15
LT3307241T (lt) 2018-12-10
CY1120883T1 (el) 2019-12-11
HK1247118A1 (zh) 2018-09-21
PL3307241T3 (pl) 2019-03-29
AU2016277336B2 (en) 2018-12-06
KR20170140301A (ko) 2017-12-20
JP6342087B1 (ja) 2018-06-13
BR112017026552B1 (pt) 2023-11-14
SA517390480B1 (ar) 2021-03-11
EP3307241B8 (fr) 2018-12-19
IL256071B (en) 2019-09-26
BR112017026552A2 (pt) 2018-08-14
IL256071A (en) 2018-01-31
TN2017000445A1 (en) 2019-04-12
RS57948B1 (sr) 2019-01-31
TR201815791T4 (tr) 2018-11-21
EP3307241B1 (fr) 2018-09-26
CN107771074B (zh) 2021-04-02
PT3307241T (pt) 2018-11-26
MA42290B1 (fr) 2018-11-30
CA2985897A1 (fr) 2016-12-15
CN107771074A (zh) 2018-03-06

Similar Documents

Publication Publication Date Title
EP3634516C0 (fr) Système d'extraction de fluide implantable
EP3600509A4 (fr) Interface patient
EP3335740C0 (fr) Hydrogel médical
MA53943A (fr) Modulateurs de ror-gamma
LU92603B1 (de) Silikonventildropper
EP3363497A4 (fr) Casque de stimulation à ultrasons
FI20155177L (fi) Virtaavan aineen venttiilijärjestely
EP3521021A4 (fr) Hydrogel
DE112016000727A5 (de) Fluidanordnung
EP3383550C0 (fr) Pulverisateur fluidique
HUE041945T2 (hu) Szemészeti szuszpenzió készítmény
PT3295244T (pt) Fluido de visualização eletroforético
DK3641931T3 (da) Fluidreaktor
EP3458307C0 (fr) Stabilisateur de charge de fluide
EP3731763A4 (fr) Interface de navigation chirurgicale générique
DE112016004411A5 (de) Fluidanordnung
MA42290A (fr) Gel fluide ophtalmique de bimatoprost
LT3324951T (lt) Peritoninis terapinis skystis
EP3524656A4 (fr) Nouvel hydrogélateur
EP3330638A4 (fr) Répartiteur de débit de fluide frigorigène
FR3029422B1 (fr) Microbille d'hydrogel
BR112017004751A2 (pt) cilindro hidráulico
FI20155649A7 (fi) Jaettu runko
FR3020112B1 (fr) Vanne de circulation de fluide
EP3648904A4 (fr) Supports élastomères sphériques